Latest headlines
Johnson & Johnson News
The latest Johnson & Johnson (JNJ) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these JNJ headlines next to the live Johnson & Johnson Fear and Greed Index.
Latest Johnson & Johnson Headlines37
Worried About the Market? These Stocks Have a Track Record of Helping Investors Sleep at Night.
fool.com · Aug 6, 2026
The Market Is Flashing a Valuation Warning -- but History Shows These Stocks Can Handle the Turbulence
fool.com · Aug 6, 2026
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
businesswire.com · Aug 4, 2026
4 Non-Tech Stocks to Grab as Dow Hits New Milestone Amid AI Sell-off
zacks.com · Aug 4, 2026
Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
businesswire.com · Aug 4, 2026
Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript
seekingalpha.com · Aug 3, 2026
J&J's Strong Q2 Oncology Performance Fuels Future Growth Hopes
zacks.com · Aug 3, 2026
Is It Worth Investing in Johnson & Johnson (JNJ) Based on Wall Street's Bullish Views?
zacks.com · Aug 3, 2026
Johnson & Johnson's OTTAVA Robotic Surgery System Targets Long-Term Growth
marketbeat.com · Aug 3, 2026
Inside J&J's Lab to Create a Simpler Robotic Surgery Device
youtube.com · Aug 2, 2026
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jul 31, 2026
Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline
benzinga.com · Jul 31, 2026
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
fool.com · Jul 31, 2026
Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About
fool.com · Jul 30, 2026
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals
benzinga.com · Jul 30, 2026
Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com · Jul 30, 2026
Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
prnewswire.com · Jul 30, 2026
Nasdaq rebounds hard as Microsoft, Apple and chipmakers rally
proactiveinvestors.com · Jul 30, 2026
Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines
wsj.com · Jul 29, 2026
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
businesswire.com · Jul 29, 2026
Johnson & Johnson lowers 2026 profit forecast
reuters.com · Jul 29, 2026
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
businesswire.com · Jul 29, 2026
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
fool.com · Jul 29, 2026
Explainer: Can J&J finally put the talc litigation behind it?
reuters.com · Jul 29, 2026
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs.
fool.com · Jul 29, 2026
These 3 Companies Reported Record Results and Raised Guidance
zacks.com · Jul 28, 2026
Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer
fastcompany.com · Jul 28, 2026
Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits
foxbusiness.com · Jul 28, 2026
Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation
proactiveinvestors.com · Jul 28, 2026
Johnson & Johnson Stock Hits Record High on $5.5 Billion Settlement
schaeffersresearch.com · Jul 28, 2026
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest
benzinga.com · Jul 28, 2026
Stock Futures Point to Another Mixed Session
schaeffersresearch.com · Jul 28, 2026
J&J offers $5.5bn to settle baby powder lawsuits
news.sky.com · Jul 28, 2026
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits
reuters.com · Jul 27, 2026
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
businesswire.com · Jul 27, 2026
J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?
zacks.com · Jul 27, 2026
If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now
fool.com · Jul 27, 2026
Why Is Johnson & Johnson Up or Down Today?
When Johnson & Johnson (JNJ) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a JNJ move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Johnson & Johnson is up or down today.
How Johnson & Johnson News Affects the Price
News does not move the Johnson & Johnson (JNJ) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Johnson & Johnson Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Johnson & Johnson trading volume. That is the chain to watch: headline, sentiment, volume, then the JNJ price.
Trade the Johnson & Johnson News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Johnson & Johnson trading volume spike on a big story, check the Johnson & Johnson price history for context, follow the live JNJ price, see the Johnson & Johnson price prediction, and read the Johnson & Johnson Fear and Greed Index for mood.
How do you feel about Johnson & Johnson?
1DFrequently asked questions
Why is Johnson & Johnson up or down today?
What is the latest Johnson & Johnson news?
Where does Johnson & Johnson news come from?
How often is Johnson & Johnson news updated?
How does Johnson & Johnson news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.